Short communication: Prevalence of extended spectrum beta-lactamases in gram negative rods: Data of 2001-2004 period;Kisa bildiri: Gram negatif çomaklarda geniş spektrumlu beta-laktamaz sikliǧi: 2001-2004 yili verileri

Mikrobiyoloji Bulteni

Volumn 40, Issue 4, 2006, Pages 355-361

  Alici, Özlem ^a   Açkigöz, Z Cibali ^b   Göçer, Safiye ^c   Gamberzade, Şöhret ^d   Karahocagil, M Kasim ^b  

^a FATIH UNIVERSITY   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

^c Akay Hastanesi   (Turkey)

^d Lokman Hekim Private Hospital   (Turkey)

Author keywords

Double disk synergy test; Extended spectrum beta lactamase; Gram negative rods

Indexed keywords

BETA LACTAMASE;

ARTICLE; BACTEREMIA; BACTERIURIA; BIOSYNTHESIS; ENZYMOLOGY; FECES; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; SPUTUM; SUPPURATION;

BACTEREMIA; BACTERIURIA; BETA-LACTAMASES; FECES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; SPUTUM; SUPPURATION;

EID: 34548067477     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Colodner R. Extended-spectrum beta-lactamases: a challenge for clinical microbiologists and infection control specialists. Am J Infect Control 2005; 33: 104-7.
2. Valverde A, Coque TM, Sanchez-Moreno MP, Rollan A, Baquero F, Canton R. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2005; 42: 4769-75.
3. Bonfiglio G, Perilli M, Stefani S, Amicosante G, Nicoletti G. Prevalence of extended spectrum beta-lactamases among Enterobacteriaceae: an Italian survey. Int J Antimicrob Agents 2002; 19: 213-7.
4. National Committee for Clinical Laboratory Standards. Performance standard for antimicrobial disk susceptibility testing. 9th Informational Supplement M100-S9. 1999, NCCLS, Wayne, PA.
5. d'Azevedo PA, Goncalves AL, Musskopf MI, Ramos CG, Dias CA. Laboratory tests in the detection of extended spectrum beta-lactamase production: National Committee for Clinical Laboratory Standards (NCCLS) screening test, the E-test, the double disk confirmatory test, and cefoxitin susceptibility testing. Braz J Infect Dis 2004; 8: 372-7.
6. Emery CL, Weymouth LA. Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center. J Clin Microbiol 1997; 35: 2061-7.
7. Acikgoz ZC, Gulay Z, Bicmen M, Gocer S, Gamberzade S. CTX-M-3 extended-spectrum beta-lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scand J Infect Dis 2003; 35: 503-5.
8. Shah AA, Hasan F, Ahmed S, Hameed A. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum β-lactamases. Res Microbiol 2004: 155: 409-21.
9. Bülüç M, Gürol Y, Bal Ç. Genişlemiş spektrumlu beta-laktamaz oranlari: 2000-2002. Türk Mikrobiyol Cern Derg 2003; 33: 31-4.
10. Dolapci I: Extended-spectrum beta-lactamases: their role in clinical microbiology laboratory, treatment and infection control. Mikrobiyol Bul 2005, 39: 229-40.
11. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G; Italian ESBL Study Group. Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs. Antimicrob Agents Chemother 2002; 46: 196-202.
12. Quinteros M, Radice M, Gardella N, et al; Microbiology Study Group, Extended-spectrum beta-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrob Agents Chemother 2003; 47: 2864-7.
13. Jones RN, Pfaller MA; The MYSTIC Study Group (Europe): Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in Europe. Clin Microbiol Infect 2003; 9: 708-12.
14. Jabeen K, Zafar A, Hasan R. Frequency and sensitivity pattern of extended spectrum beta lactamase producing isolates in a tertiary care hospital laboratory of Pakistan. J Pak Med Assoc 2005; 55: 436-9.
15. El-Khizzi NA, Bakheshwain SM. Prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital. Saudi Med J 2006; 27: 37-40.
16. Chow JW, Satishchandran V, Snyder TA, Harvey CM, Friedland IR, Dinubile MJ. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect (Larchmt) 2005; 6: 439-48.
17. Akata F, Tatman-Otkun M, Ozkan E, Tansel O, Otkun M, Tugrul M. Prevalence of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae in Trakya University Hospital, Turkey. New Microbiol 2003; 26: 257-62.
18. Leblebicioglu H, Gunaydin M, Esen S, et al; Study Group: Surveillance of antimicrobial resistance in gram-negative isolates from intensive care units in Turkey: analysis of data from the last 5 years. J Chemother 2002; 14: 140-6.
19. Kucukates E. Antimicrobial resistance among Gram-negative bacteria isolated from intensive care units in a Cardiology Institute in Istanbul, Turkey. Jpn J Infect Dis 2005; 58: 228.
20. Yaman A, Tasova Y, Kibar F, et al. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections. Saudi Med J 2004; 25: 1403-9.
21. Dandekar PK, Tetreault J, Quinn JP, Nightingale CH, Nicolau DP. Prevalence of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella isolates in a large community teaching hospital in Connecticut. Diagn Microbiol Infect Dis 2004; 49: 37-9.